{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:49:38Z","timestamp":1782978578960,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Sepsis is a syndrome of systemic inflammatory reaction caused by a severe infection, leading to multiorgan damage and a high mortality rate. In recent years, several studies have shown that decoy receptor 3 (DcR3) is positively correlated with the severity of infection, and its high specificity and sensitivity in the diagnosis of sepsis is expected to serve as a novel marker for sepsis. This meta-analysis aims to evaluate the diagnostic accuracy of decoy receptor 3 (DcR3) for sepsis in the intensive care unit (ICU) setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a comprehensive search in six databases, extracting data independently.Studies were included if they assessed the diagnostic accuracy of DcR3 for sepsis in the intensive care unit (ICU). A meta-analysis was performed using a random-effects model to calculate pooled sensitivity, specificity, and area under the curve (AUC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four records assessing 681 patients were included in this meta-analysis. In distinguishing sepsis from normal controls, DcR3 demonstrated exceptional discriminatory power with an AUC of 0.99. The pooled sensitivity was 0.98 (95% CI 0.95\u20130.99), and the pooled specificity was 0.95 (95% CI 0.92\u20130.97). The pooled PLR was 21.21 (95% CI 12.71\u201335.40), the pooled NLR was 0.02 (95% CI 0.01\u20130.06), and the pooled DOR was 878.26 (95% CI 217.36\u201321062.55). In differentiating sepsis from systemic inflammatory response syndrome (SIRS), the AUC was 0.95. The pooled sensitivity was 0.93 (95% CI 0.87\u20130.96), and the pooled specificity was 0.87 (95% CI 0.68\u20130.95). The pooled PLR was 6.89 (95% CI 2.67\u201318.26), the pooled NLR was 0.08 (95% CI 0.04\u20130.15), and the pooled DOR was 86.17 (95% CI 27.35\u2013271.55).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>On the basis of our meta-analysis, DcR3 is a helpful marker for early diagnosis of sepsis on ICU admission. However, the findings are limited by the small number of included studies and significant heterogeneity. Further large-scale, multicenter prospective studies are warranted to validate these results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40635-026-00943-z","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:22:40Z","timestamp":1782976960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Decoy receptor 3 as a diagnostic marker for sepsis: a meta-analysis"],"prefix":"10.1186","volume":"14","author":[{"given":"Xiao-Ke","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Yue","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Zhen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ya","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Xiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4236-1666","authenticated-orcid":false,"given":"Li-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"943_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:801\u2013810","journal-title":"JAMA"},{"key":"943_CR2","doi-asserted-by":"crossref","unstructured":"Dickmann P, Claus RA, Bauer M (2025) Sepsis after Trauma\u2014Evolving Paradigms in Stress Biology and Host Resp onse Failure. Burns & Trauma","DOI":"10.1093\/burnst\/tkaf014"},{"key":"943_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s41038-017-0089-5","author":"DG Greenhalgh","year":"2017","unstructured":"Greenhalgh DG (2017) Sepsis in the burn patient: a different problem than sepsis in the general population. Burns & Trauma. https:\/\/doi.org\/10.1186\/s41038-017-0089-5","journal-title":"Burns & Trauma"},{"key":"943_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/aas.13747","volume":"65","author":"E Vesteinsdottir","year":"2021","unstructured":"Vesteinsdottir E, Gottfredsson M, Blondal A, Sigurdsson MI, Karason S (2021) Sepsis after elective surgery - Incidence, aetiology and outcome. Acta Anaesthesiol Scand 65:457\u2013465","journal-title":"Acta Anaesthesiol Scand"},{"key":"943_CR5","first-page":"199","volume":"56","author":"EJ Nelwan","year":"2024","unstructured":"Nelwan EJ, Yulisar RN, Adiwinata R, Rinaldi I, Rumende CM, Sinto R (2024) Diagnostic accuracy of serum procalcitonin to diagnose sepsis in advan ced solid tumor patients with fever. Acta Med Indones 56:199\u2013205","journal-title":"Acta Med Indones"},{"key":"943_CR6","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/s13054-020-02950-2","volume":"24","author":"M Bauer","year":"2020","unstructured":"Bauer M, Gerlach H, Vogelmann T, Preissing F, Stiefel J, Adam D (2020) Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis. Crit Care 24:239","journal-title":"Crit Care"},{"key":"943_CR7","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM et al (2020) Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet 395:200\u2013211","journal-title":"Lancet"},{"key":"943_CR8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3389\/fphar.2019.00906","volume":"10","author":"J Su","year":"2019","unstructured":"Su J, Guo K, Huang M et al (2019) Fucoxanthin, a Marine Xanthophyll Isolated From Conticribra weissflogii ND-8: Preventive Anti-Inflammatory Effect in a Mouse Model of Sepsis. Front Pharmacol 10:906","journal-title":"Front Pharmacol"},{"key":"943_CR9","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201810128","author":"JM Cavaillon","year":"2020","unstructured":"Cavaillon JM, Singer M, Skirecki T (2020) Sepsis therapies: learning from 30 years of failure of translational research to propose new leads. EMBO Mol Med. https:\/\/doi.org\/10.15252\/emmm.201810128","journal-title":"EMBO Mol Med"},{"key":"943_CR10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41401-021-00676-7","volume":"43","author":"C Deng","year":"2022","unstructured":"Deng C, Zhao L, Yang Z et al (2022) Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury. Acta Pharmacol Sin 43:520\u2013528","journal-title":"Acta Pharmacol Sin"},{"key":"943_CR11","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.3389\/fimmu.2019.02400","volume":"10","author":"B McDonald","year":"2019","unstructured":"McDonald B, Dunbar M (2019) Platelets and Intravascular Immunity: Guardians of the Vascular Space During Bloodstream Infections and Sepsis. Front Immunol 10:2400","journal-title":"Front Immunol"},{"key":"943_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/25387","volume":"396","author":"RM Pitti","year":"1998","unstructured":"Pitti RM, Marsters SA, Lawrence DA et al (1998) Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396:699\u2013703","journal-title":"Nature"},{"key":"943_CR13","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s12026-021-09218-z","volume":"69","author":"A Kamal","year":"2021","unstructured":"Kamal A, Abdelmegeid AK, Gabr MAM, Basanti CWS (2021) Serum decoy receptor 3 (DcR3): a promising biomarker for atopic asthma in children. Immunol Res 69:568\u2013575","journal-title":"Immunol Res"},{"key":"943_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.891328","volume":"13","author":"WD Xu","year":"2022","unstructured":"Xu WD, Li R, Huang AF (2022) Role of TL1A in inflammatory autoimmune diseases: a comprehensive review. Front Immunol 13:891328","journal-title":"Front Immunol"},{"key":"943_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00408-020-00348-z","volume":"198","author":"H Ghobadi","year":"2020","unstructured":"Ghobadi H, Hosseini N, Aslani MR (2020) Correlations between serum decoy receptor 3 and airflow limitation and quality of life in male patients with stable stage and acute exacerbation of COPD. Lung 198:515\u2013523","journal-title":"Lung"},{"key":"943_CR16","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s13054-020-02913-7","volume":"24","author":"P van der Zee","year":"2020","unstructured":"van der Zee P, Rietdijk W, Somhorst P, Endeman H, Gommers D (2020) A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality. Crit Care 24:243","journal-title":"Crit Care"},{"key":"943_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.21873\/cdp.10124","volume":"2","author":"S Lagou","year":"2022","unstructured":"Lagou S, Grapsa D, Syrigos N, Bamias G (2022) The role of decoy receptor DcR3 in gastrointestinal malignancy. Cancer Diagn Progn 2:411\u2013421","journal-title":"Cancer Diagn Progn"},{"key":"943_CR18","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s12885-020-07058-y","volume":"20","author":"MJ Bou-Dargham","year":"2020","unstructured":"Bou-Dargham MJ, Sha L, Sang QA, Zhang J (2020) Immune landscape of human prostate cancer: immune evasion mechanisms and biomarkers for personalized immunotherapy. BMC Cancer 20:572","journal-title":"BMC Cancer"},{"key":"943_CR19","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.21037\/jgo-21-303","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C, Li H, Huang Y et al (2021) Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. J Gastrointest Oncol 12:1673\u20131690","journal-title":"J Gastrointest Oncol"},{"key":"943_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2020","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2020) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med 18:e1003583","journal-title":"PLoS Med"},{"key":"943_CR21","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AWS, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529\u2013536","journal-title":"Ann Intern Med"},{"key":"943_CR22","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.cca.2012.01.007","volume":"413","author":"YQ Hou","year":"2012","unstructured":"Hou YQ, Xu P, Zhang M et al (2012) Serum decoy receptor 3, a potential new biomarker for sepsis. Clin Chim Acta 413:744\u2013748","journal-title":"Clin Chim Acta"},{"key":"943_CR23","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.diagmicrobio.2012.04.008","volume":"73","author":"S Kim","year":"2012","unstructured":"Kim S, Mi L, Zhang L (2012) Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis. Diagn Microbiol Infect Dis 73:312\u2013317","journal-title":"Diagn Microbiol Infect Dis"},{"key":"943_CR24","doi-asserted-by":"publisher","first-page":"10934","DOI":"10.18632\/oncotarget.23736","volume":"9","author":"L Gao","year":"2018","unstructured":"Gao L, Yang B, Zhang H (2018) DcR3, a new biomarker for sepsis, correlates with infection severity and procalcitonin. Oncotarget 9:10934\u201310944","journal-title":"Oncotarget"},{"key":"943_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s11658-018-0087-z","volume":"23","author":"JJ Zhao","year":"2018","unstructured":"Zhao JJ, Lou XL, Chen HW, Zhu FT, Hou YQ (2018) Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis. Cell Mol Biol Lett 23:22","journal-title":"Cell Mol Biol Lett"},{"key":"943_CR26","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1097\/CCM.0000000000004155","volume":"48","author":"J Xie","year":"2020","unstructured":"Xie J, Wang H, Kang Y et al (2020) The Epidemiology of Sepsis in Chinese ICUs: A National Cross-Sectional Survey. Crit Care Med 48:e209\u2013e218","journal-title":"Crit Care Med"},{"key":"943_CR27","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s10096-019-03601-3","volume":"38","author":"E Grande","year":"2019","unstructured":"Grande E, Grippo F, Frova L, Pantosti A, Pezzotti P, Fedeli U (2019) The increase of sepsis-related mortality in Italy: a nationwide study, 2003\u20132015. Eur J Clin Microbiol Infect Dis 38:1701\u20131708","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"943_CR28","doi-asserted-by":"publisher","first-page":"ii33","DOI":"10.1093\/jac\/dkq523","volume":"66","author":"S Kibe","year":"2011","unstructured":"Kibe S, Adams K, Barlow G (2011) Diagnostic and prognostic biomarkers of sepsis in critical care. J Antimicrob Chemother 66:ii33\u2013ii40","journal-title":"J Antimicrob Chemother"},{"key":"943_CR29","doi-asserted-by":"publisher","first-page":"332","DOI":"10.7150\/ijms.39367","volume":"17","author":"R Paudel","year":"2020","unstructured":"Paudel R, Dogra P, Montgomery-Yates AA, Coz Yataco A, Procalcitonin (2020) A promising tool or just another overhyped test? Int J Med Sci 17:332\u2013337","journal-title":"Int J Med Sci"},{"key":"943_CR30","doi-asserted-by":"crossref","unstructured":"Dunne WM Jr. (2015) Laboratory Diagnosis of Sepsis? No SIRS, Not Just Yet. J Clin Microbiol 53:2404\u20132409","DOI":"10.1128\/JCM.03681-14"},{"key":"943_CR31","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1093\/jbcr\/irz170","volume":"42","author":"D Min","year":"2021","unstructured":"Min D, Wu B, Chen L et al (2021) Level of Decoy Receptor 3 for Monitoring Clinical Progression of Severe Burn Patients. J Burn Care Res 42:925\u2013933","journal-title":"J Burn Care Res"},{"key":"943_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612916","author":"J Su","year":"2023","unstructured":"Su J, Tong Z, Wu S, Zhou F, Chen Q (2023) Research progress of DcR3 in the diagnosis and treatment of sepsis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241612916","journal-title":"Int J Mol Sci"},{"key":"943_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1097\/MEJ.0000000000001235","volume":"32","author":"C-L Chuang","year":"2025","unstructured":"Chuang C-L, Yeh H-T, Niu K-Y, Chen C-B, Seak C-J, Yen C-C (2025) Diagnostic performances of procalcitonin and C-reactive protein for sepsis: a systematic review and meta-analysis. Eur J Emerg Med 32:248\u2013258","journal-title":"Eur J Emerg Med"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00943-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-026-00943-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-026-00943-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:22:48Z","timestamp":1782976968000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40635-026-00943-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["943"],"URL":"https:\/\/doi.org\/10.1186\/s40635-026-00943-z","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.\u00a0This manuscript does not report on primary studies involving human tissue and animal data. The human data reported in this manuscript were derived from previously published literature. As a systematic review and meta-analysis, this study does not require direct ethical approval or patient informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We declare that we have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}